Arvinas Banner Image

Arvinas has reached its limit for free report views

Work for Arvinas? Upgrade Your Profile and unlock all your annual reports.


  • Ticker ARVN
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Arvinas Logo Image
  • 51-200 Employees
Arvinas is a biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Arvinas uses its proprietary technology platform to engineer proteolysis targeting chimeras, or PROTAC™ protein degraders, that are designedMore to harness the body’s own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins.

Most Recent Annual Report

Arvinas MOST RECENT 2019 Annual Report and Form 10K

Report Locked. Arvinas has reached its limit for free report views.

Older/Archived Annual Reports